Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Opposite Roles for ZEB1 and TMEJ in the Regulation of Breast Cancer Genome Stability.
Prodhomme MK, Péricart S, Pommier RM, Morel AP, Brunac AC, Franchet C, Moyret-Lalle C, Brousset P, Puisieux A, Hoffmann JS, Tissier A. Prodhomme MK, et al. Among authors: tissier a. Front Cell Dev Biol. 2021 Aug 12;9:727429. doi: 10.3389/fcell.2021.727429. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34458275 Free PMC article. Review.
EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers.
Prodhomme MK, Pommier RM, Franchet C, Fauvet F, Bergoglio V, Brousset P, Morel AP, Brunac AC, Devouassoux-Shisheboran M, Petrilli V, Moyret-Lalle C, Hoffmann JS, Puisieux A, Tissier A. Prodhomme MK, et al. Among authors: tissier a. Cancer Res. 2021 Mar 15;81(6):1595-1606. doi: 10.1158/0008-5472.CAN-20-2626. Epub 2020 Nov 25. Cancer Res. 2021. PMID: 33239429
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.
Morel AP, Ginestier C, Pommier RM, Cabaud O, Ruiz E, Wicinski J, Devouassoux-Shisheboran M, Combaret V, Finetti P, Chassot C, Pinatel C, Fauvet F, Saintigny P, Thomas E, Moyret-Lalle C, Lachuer J, Despras E, Jauffret JL, Bertucci F, Guitton J, Wierinckx A, Wang Q, Radosevic-Robin N, Penault-Llorca F, Cox DG, Hollande F, Ansieau S, Caramel J, Birnbaum D, Vigneron AM, Tissier A, Charafe-Jauffret E, Puisieux A. Morel AP, et al. Among authors: tissier a. Nat Med. 2017 May;23(5):568-578. doi: 10.1038/nm.4323. Epub 2017 Apr 10. Nat Med. 2017. PMID: 28394329
The cell-of-origin dictates the genomic landscape of breast cancers.
Puisieux A, Pommier RM, Tissier A, Morel AP. Puisieux A, et al. Among authors: tissier a. Mol Cell Oncol. 2017 Jun 16;4(4):e1338931. doi: 10.1080/23723556.2017.1338931. eCollection 2017. Mol Cell Oncol. 2017. PMID: 28868351 Free PMC article.
EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
Morel AP, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, Wierinckx A, Devouassoux-Shisheboran M, Treilleux I, Tissier A, Gras B, Pourchet J, Puisieux I, Browne GJ, Spicer DB, Lachuer J, Ansieau S, Puisieux A. Morel AP, et al. Among authors: tissier a. PLoS Genet. 2012;8(5):e1002723. doi: 10.1371/journal.pgen.1002723. Epub 2012 May 24. PLoS Genet. 2012. PMID: 22654675 Free PMC article.
PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.
Beck C, Rodriguez-Vargas JM, Boehler C, Robert I, Heyer V, Hanini N, Gauthier LR, Tissier A, Schreiber V, Elofsson M, Reina San Martin B, Dantzer F. Beck C, et al. Among authors: tissier a. Cell Death Differ. 2019 Sep;26(9):1615-1630. doi: 10.1038/s41418-018-0233-1. Epub 2018 Nov 15. Cell Death Differ. 2019. PMID: 30442946 Free PMC article.
124 results